216 related articles for article (PubMed ID: 25478892)
1. Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions.
Finotti A; Bianchi N; Fabbri E; Borgatti M; Breveglieri G; Gasparello J; Gambari R
Pharmacol Res; 2015 Jan; 91():57-68. PubMed ID: 25478892
[TBL] [Abstract][Full Text] [Related]
2. Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.
Bianchi N; Finotti A; Ferracin M; Lampronti I; Zuccato C; Breveglieri G; Brognara E; Fabbri E; Borgatti M; Negrini M; Gambari R
PLoS One; 2015; 10(4):e0121567. PubMed ID: 25849663
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.
Dai Q; Xie F; Han Y; Ma X; Zhou S; Jiang L; Zou W; Wang J
J Biol Chem; 2017 Jan; 292(1):196-204. PubMed ID: 27879318
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
6. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells.
Preitschopf A; Schörghofer D; Kinslechner K; Schütz B; Zwickl H; Rosner M; Joó JG; Nehrer S; Hengstschläger M; Mikula M
Stem Cells Transl Med; 2016 May; 5(5):580-90. PubMed ID: 27025692
[TBL] [Abstract][Full Text] [Related]
9. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
10. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR).
Agrawal P; Chen YT; Schilling B; Gibson BW; Hughes RE
J Biol Chem; 2012 Jun; 287(25):21164-75. PubMed ID: 22544753
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
[TBL] [Abstract][Full Text] [Related]
13. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
Hoshii T; Kasada A; Hatakeyama T; Ohtani M; Tadokoro Y; Naka K; Ikenoue T; Ikawa T; Kawamoto H; Fehling HJ; Araki K; Yamamura K; Matsuda S; Hirao A
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3805-10. PubMed ID: 24567410
[TBL] [Abstract][Full Text] [Related]
14. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin-Resistant mTOR Activity Is Required for Sensory Axon Regeneration Induced by a Conditioning Lesion.
Chen W; Lu N; Ding Y; Wang Y; Chan LT; Wang X; Gao X; Jiang S; Liu K
eNeuro; 2016; 3(6):. PubMed ID: 28101526
[TBL] [Abstract][Full Text] [Related]
16. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.
Habib SL; Yadav A; Kidane D; Weiss RH; Liang S
Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085
[TBL] [Abstract][Full Text] [Related]
17. Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.
Iwata TN; Ramírez JA; Tsang M; Park H; Margineantu DH; Hockenbery DM; Iritani BM
J Immunol; 2016 Sep; 197(6):2250-60. PubMed ID: 27521345
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells.
Kim EY; Kim A; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Respir Res; 2014 Feb; 15(1):26. PubMed ID: 24571487
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.
Coffman K; Yang B; Lu J; Tetlow AL; Pelliccio E; Lu S; Guo DC; Tang C; Dong MQ; Tamanoi F
J Biol Chem; 2014 Feb; 289(8):4723-34. PubMed ID: 24403073
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction.
Li B; Li Z; Wang P; Huang Q; Xu L; He R; Ye L; Bai Q
Immunology; 2017 Oct; 152(2):276-286. PubMed ID: 28557002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
